• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在协变量时最小有效剂量和峰值剂量的自适应等张估计

Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of Covariates.

作者信息

Xiao Changfu, Ivanova Anastasia

机构信息

Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599-7420, USA.

出版信息

J Stat Plan Inference. 2012 Jul 1;142(7):1899-1907. doi: 10.1016/j.jspi.2012.01.024.

DOI:10.1016/j.jspi.2012.01.024
PMID:22711972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3375738/
Abstract

We consider a problem of estimating the minimum effective and peak doses in the presence of covariates. We propose a sequential strategy for subject assignment that includes an adaptive randomization component to balance the allocation to placebo and active doses with respect to covariates. We conclude that either adjusting for covariates in the model or balancing allocation with respect to covariates is required to avoid bias in the target dose estimation. We also compute optimal allocation to estimate the minimum effective and peak doses in discrete dose space using isotonic regression.

摘要

我们考虑在存在协变量的情况下估计最小有效剂量和峰值剂量的问题。我们提出了一种受试者分配的序贯策略,该策略包括一个自适应随机化组件,以在协变量方面平衡安慰剂和活性剂量的分配。我们得出结论,为避免目标剂量估计中的偏差,需要在模型中对协变量进行调整或在协变量方面平衡分配。我们还使用保序回归计算了在离散剂量空间中估计最小有效剂量和峰值剂量的最优分配。

相似文献

1
Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of Covariates.存在协变量时最小有效剂量和峰值剂量的自适应等张估计
J Stat Plan Inference. 2012 Jul 1;142(7):1899-1907. doi: 10.1016/j.jspi.2012.01.024.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.最小充分平衡——平衡基线协变量并保持治疗分配随机性的新策略。
Stat Methods Med Res. 2015 Dec;24(6):989-1002. doi: 10.1177/0962280212436447. Epub 2012 Jan 26.
4
k-Resolution sequential randomization procedure to improve covariates balance in a randomized experiment.k-分辨率序贯随机化程序,改善随机试验中协变量的平衡。
Stat Med. 2021 Nov 10;40(25):5534-5546. doi: 10.1002/sim.9139. Epub 2021 Jul 13.
5
Covariate selection for optimizing balance with an innovative adaptive randomization approach.采用创新的自适应随机化方法进行协变量选择以优化均衡性。
Stat Methods Med Res. 2025 Sep;34(9):1751-1779. doi: 10.1177/09622802241313283. Epub 2025 Apr 13.
6
The impact of misclassification on covariate-adaptive randomized clinical trials.混杂因素自适应随机临床试验中分类错误的影响。
Biometrics. 2021 Jun;77(2):451-464. doi: 10.1111/biom.13308. Epub 2020 Jun 7.
7
A simple, flexible, and effective covariate-adaptive treatment allocation procedure.一种简单、灵活且有效的协变量自适应治疗分配程序。
Stat Med. 2013 Sep 30;32(22):3775-87. doi: 10.1002/sim.5837. Epub 2013 May 2.
8
Regression-based multiple treatment effect estimation under covariate-adaptive randomization.基于回归的协变量自适应随机化下的多种处理效应估计。
Biometrics. 2023 Dec;79(4):2869-2880. doi: 10.1111/biom.13925. Epub 2023 Sep 12.
9
Rerandomization to Balance Tiers of Covariates.重新随机化以平衡协变量层次
J Am Stat Assoc. 2015;110(512):1412-1421. doi: 10.1080/01621459.2015.1079528. Epub 2016 Jan 15.
10
Simulation and minimization: technical advances for factorial experiments designed to optimize clinical interventions.模拟与最小化:优化临床干预的析因实验设计的技术进展。
BMC Med Res Methodol. 2019 Dec 16;19(1):239. doi: 10.1186/s12874-019-0883-9.

引用本文的文献

1
Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designs.当目标剂量处于剂量反应曲线的平台期时的剂量探索:完全序贯设计的比较
Pharm Stat. 2013 Sep-Oct;12(5):309-14. doi: 10.1002/pst.1585. Epub 2013 Jul 26.

本文引用的文献

1
Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designs.当目标剂量处于剂量反应曲线的平台期时的剂量探索:完全序贯设计的比较
Pharm Stat. 2013 Sep-Oct;12(5):309-14. doi: 10.1002/pst.1585. Epub 2013 Jul 26.
2
Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.使用贝叶斯等渗变换在I/II期临床试验中进行剂量-给药方案探索
Stat Med. 2008 Oct 30;27(24):4895-913. doi: 10.1002/sim.3329.
3
Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.具有单调目标函数的连续和有序结果的剂量确定:一种统一方法。
Biometrics. 2009 Mar;65(1):307-15. doi: 10.1111/j.1541-0420.2008.01045.x. Epub 2008 May 13.
4
Patient-specific dose finding based on bivariate outcomes and covariates.基于双变量结果和协变量的个体化剂量确定。
Biometrics. 2008 Dec;64(4):1126-36. doi: 10.1111/j.1541-0420.2008.01009.x. Epub 2008 Mar 19.
5
Monitoring late-onset toxicities in phase I trials using predicted risks.利用预测风险监测I期试验中的迟发性毒性。
Biostatistics. 2008 Jul;9(3):442-57. doi: 10.1093/biostatistics/kxm044. Epub 2007 Dec 14.
6
Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control.具有对照组的多臂随机临床试验中用于治疗选择的简单序贯界值
Biometrics. 2008 Sep;64(3):940-949. doi: 10.1111/j.1541-0420.2007.00929.x. Epub 2007 Oct 19.
7
Isotonic designs for phase I cancer clinical trials with multiple risk groups.针对具有多个风险组的I期癌症临床试验的等渗设计。
Clin Trials. 2004;1(6):499-508. doi: 10.1191/1740774504cn058oa.
8
Bivariate isotonic design for dose-finding with ordered groups.用于有序组剂量探索的双变量等渗设计
Stat Med. 2006 Jun 30;25(12):2018-26. doi: 10.1002/sim.2312.
9
Combining multiple comparisons and modeling techniques in dose-response studies.在剂量反应研究中结合多种比较和建模技术。
Biometrics. 2005 Sep;61(3):738-48. doi: 10.1111/j.1541-0420.2005.00344.x.
10
Designs for single- or multiple-agent phase I trials.单药或多药I期试验的设计。
Biometrics. 2004 Sep;60(3):661-9. doi: 10.1111/j.0006-341X.2004.00215.x.